These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2028807)

  • 21. The dexamethasone suppression test: importance of dexamethasone concentrations.
    Maguire KP; Schweitzer I; Biddle N; Bridge S; Tiller JW
    Biol Psychiatry; 1987 Aug; 22(8):957-67. PubMed ID: 3607137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of the DST results in depressives by means of urinary-free cortisol excretion, dexamethasone levels, and age.
    Maes M; Jacobs MP; Suy E; Minner B; Raus J
    Biol Psychiatry; 1990 Aug; 28(4):349-57. PubMed ID: 2397250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age, medical illness, and the DST in depressed general hospital inpatients.
    Fogel BS; Satel SL
    J Clin Psychiatry; 1985 Mar; 46(3):95-7. PubMed ID: 3972780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma L-tryptophan/neutral amino acid ratio and dexamethasone suppression in depression.
    Joseph MS; Brewerton TD; Reus VI; Stebbins GT
    Psychiatry Res; 1984 Mar; 11(3):185-92. PubMed ID: 6587412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of solid-phase radioimmunoassay and competitive protein binding method for postdexamethasone cortisol levels in psychiatric patients.
    Wilens TE; Arana GW; Baldessarini RJ; Cremens C
    Psychiatry Res; 1983 Mar; 8(3):199-206. PubMed ID: 6574539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dexamethasone suppression test in panic disorder.
    Judd FK; Norman TR; Burrows GD; McIntyre IM
    Pharmacopsychiatry; 1987 May; 20(3):99-101. PubMed ID: 3602097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dexamethasone suppression test and quantitative cerebral anatomy in depression.
    Coffey CE; Wilkinson WE; Weiner RD; Ritchie JC; Aque M
    Biol Psychiatry; 1993 Mar; 33(6):442-9. PubMed ID: 8490071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of serum dexamethasone concentrations in the dexamethasone suppression test.
    Carr V; Morris H; Gilliland J
    Biol Psychiatry; 1986 Jul; 21(8-9):735-43. PubMed ID: 3730458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postdexamethasone prolactin and cortisol: a biological state variable in depression.
    Klein HE; Seibold B; Bender W; Nedopil N; Albus M; Schmauss M
    Acta Psychiatr Scand; 1984 Sep; 70(3):239-47. PubMed ID: 6496148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 4 p.m. baseline cortisol level as a predictor of DST results in depression.
    Weiler MA; Jobe TH; Nasr SJ; Pandey G; Altman EG
    J Clin Psychiatry; 1986 Feb; 47(2):60-2. PubMed ID: 3944064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DST in depression is unaffected by altering the clock time of its administration.
    Pepper GM; Davis KL; Davis BM; Krieger DT
    Psychiatry Res; 1983 Feb; 8(2):105-9. PubMed ID: 6574528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility.
    Carroll BJ; Feinberg M; Greden JF; Tarika J; Albala AA; Haskett RF; James NM; Kronfol Z; Lohr N; Steiner M; de Vigne JP; Young E
    Arch Gen Psychiatry; 1981 Jan; 38(1):15-22. PubMed ID: 7458567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of plasma cortisol and corticosterone in the dexamethasone suppression test for melancholia.
    Wilens TE; Ritchie JC; Carroll BJ
    Psychoneuroendocrinology; 1984; 9(1):45-55. PubMed ID: 6739664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cortisol responses to 5-hydroxytryptophan, orally, in depressive inpatients.
    Maes M; De Ruyter M; Claes R; Bosma G; Suy E
    J Affect Disord; 1987; 13(1):23-30. PubMed ID: 2959697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma dexamethasone concentrations and differential suppression response of cortisol and corticosterone in depressives and controls.
    Holsboer F; Haack D; Gerken A; Vecsei P
    Biol Psychiatry; 1984 Mar; 19(3):281-91. PubMed ID: 6722226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dexamethasone suppression in dementia, depression, and normal aging.
    Georgotas A; McCue RE; Kim OM; Hapworth WE; Reisberg B; Stoll PM; Sinaiko E; Fanelli C; Stokes PE
    Am J Psychiatry; 1986 Apr; 143(4):452-6. PubMed ID: 3953888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dexamethasone suppression test in the clinical setting.
    Evans DL; Burnett GB; Nemeroff CB
    Am J Psychiatry; 1983 May; 140(5):586-9. PubMed ID: 6342422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. I. Enhanced response in depression and mania.
    Meltzer HY; Umberkoman-Wiita B; Robertson A; Tricou BJ; Lowy M; Perline R
    Arch Gen Psychiatry; 1984 Apr; 41(4):366-74. PubMed ID: 6608335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dexamethasone suppression test response in major depression: stability across hospitalizations.
    Coryell W; Schlesser MA
    Psychiatry Res; 1983 Mar; 8(3):179-89. PubMed ID: 6574537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dexamethasone suppression test and pituitary-adrenocortical function.
    Brown WA; Keitner G; Qualls CB; Haier R
    Arch Gen Psychiatry; 1985 Feb; 42(2):121-3. PubMed ID: 3977539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.